Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
ESC to deliver educational programme on cardiovascular disease in Beijing

ESC to deliver educational programme on cardiovascular disease in Beijing

Patients with AF can benefit from Medtronic Phased RF Ablation System ablation system

Patients with AF can benefit from Medtronic Phased RF Ablation System ablation system

New WPI smart-phone app can measure heart rhythm, respiration and pulse rate

New WPI smart-phone app can measure heart rhythm, respiration and pulse rate

Study calls for review of current treatment strategies, more research into stroke prevention

Study calls for review of current treatment strategies, more research into stroke prevention

Four teams receive commercialization grant awards for development of new health-care products

Four teams receive commercialization grant awards for development of new health-care products

Review of stroke treatment could save lives

Review of stroke treatment could save lives

Research roundup: Widows and medical spending; disparities in heart care, hospital deaths

Research roundup: Widows and medical spending; disparities in heart care, hospital deaths

Loyola tests new pressure-sensing catheter to treat atrial fibrillation

Loyola tests new pressure-sensing catheter to treat atrial fibrillation

Majority of cryoballoon ablation patients show no signs of A-Fib year after procedure

Majority of cryoballoon ablation patients show no signs of A-Fib year after procedure

Largest cardiology conference in Latin America

Largest cardiology conference in Latin America

Huge economic, social and personal burden of AF-related strokes across Latin America

Huge economic, social and personal burden of AF-related strokes across Latin America

FDA panel votes 9-2 in favor of new blood thinner drug

FDA panel votes 9-2 in favor of new blood thinner drug

Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban

Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban

FDA stalls the blood-thinner Xarelto’s approval citing inadequate evidence

FDA stalls the blood-thinner Xarelto’s approval citing inadequate evidence

Results of darexaban phase II trial in recent acute coronary syndrome presented at ESC Congress

Results of darexaban phase II trial in recent acute coronary syndrome presented at ESC Congress

Study finds higher incidence of arrhythmias in elite cross-country skiers

Study finds higher incidence of arrhythmias in elite cross-country skiers

Bristol Meyer Squibb’s new blood thinner drug for stroke prevention

Bristol Meyer Squibb’s new blood thinner drug for stroke prevention

Dabigatran etexilate superior to warfarin for stroke prevention in AF patients

Dabigatran etexilate superior to warfarin for stroke prevention in AF patients

AF AWARE campaign launches Atrial Fibrillation in Primary Care tool

AF AWARE campaign launches Atrial Fibrillation in Primary Care tool

Thirty two projects to receive €1M donation for prevention of AF-related stroke

Thirty two projects to receive €1M donation for prevention of AF-related stroke

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.